These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6782550)

  • 1. [Liver toxicity of androgen therapy in aplastic anemia].
    Pecking A; Lejolly JM; Najean Y
    Nouv Rev Fr Hematol (1978); 1980; 22(3):257-65. PubMed ID: 6782550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen therapy of aplastic anaemia--a prospective study of 352 cases.
    Scand J Haematol; 1979 Apr; 22(4):343-56. PubMed ID: 472658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.
    Velazquez I; Alter BP
    Am J Hematol; 2004 Nov; 77(3):257-67. PubMed ID: 15495253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and evolution of acquired aplastic anemia in childhood. A prospective analysis of 48 androgen-treated cases.
    Najean Y; Girot R; Baumelou E
    Am J Pediatr Hematol Oncol; 1982; 4(3):273-83. PubMed ID: 6756191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. French Cooperative Group for the Study of Aplastic and Refractory Anemias.
    Scand J Haematol; 1986 Apr; 36(4):346-52. PubMed ID: 2872720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of aplastic anemia with cyclosporine, prednisolone and androgens (primary results apropos of 10 cases].
    Frikha M; Sahnoun Z; Kaabachi S; Elloumi M; Gargouri J; Dammak J; Zeghal KM; Souissi T
    Therapie; 1996; 51(6):627-9. PubMed ID: 9163998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature.
    Itterbeek P; Vandenberghe P; Nevens F; Fevery J; Aerts R; Yap SH; Demuynck H; Fourneau I; Koshiba T; Emonds MP; Roskams T; Boogaerts M; Pirenne J
    Transpl Int; 2002 Mar; 15(2-3):117-23. PubMed ID: 11935168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of Fanconi's disease and hepatic tumor in a patient undergoing long-term androgen treatment].
    Corberand J; Pris J; Dutau G; Rumeau JL; Regnier C
    Arch Fr Pediatr; 1975 Mar; 32(3):275-863. PubMed ID: 1225249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of aplastic anemia: a prospective multicenter study.
    Montané E; Ibáñez L; Vidal X; Ballarín E; Puig R; García N; Laporte JR;
    Haematologica; 2008 Apr; 93(4):518-23. PubMed ID: 18322256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens.
    Leleu X; Terriou L; Duhamel A; Moreau AS; Andrieux J; Dupire S; Coiteux V; Berthon C; Micol JB; Guieze R; Facon T; Bauters F
    Ann Hematol; 2006 Oct; 85(10):711-6. PubMed ID: 16830141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophy and hyperplasia of islets of Langerhans associated with androgen therapy.
    Novak R; Wilimas J; Johnson W
    Arch Pathol Lab Med; 1979 Aug; 103(9):483-5. PubMed ID: 380511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myeloproliferative disorder and hepatocellular adenoma following androgen treatment of a patient with aplastic anemia (author's transl)].
    Tsunematsu Y; Sasaki M; Koide T; Shimizu K
    Rinsho Ketsueki; 1978 Dec; 19(12):1699-707. PubMed ID: 216824
    [No Abstract]   [Full Text] [Related]  

  • 15. [Refractory anemias with partial myeloblastosis. Analysis of a protocol comprising 79 cases. 1. Clinical characteristics and evolution under androgen therapy].
    Najean Y; Pecking A; Broquet M
    Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):67-80. PubMed ID: 1065863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is the interest of Klinefelter's syndrome for (child) psychiatrists?].
    Kebers F; Janvier S; Colin A; Legros JJ; Ansseau M
    Encephale; 2002; 28(3 Pt 1):260-5. PubMed ID: 12091788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary angioedema: Safety of long-term stanozolol therapy.
    Sloane DE; Lee CW; Sheffer AL
    J Allergy Clin Immunol; 2007 Sep; 120(3):654-8. PubMed ID: 17765757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term survival of patients with bone marrow aplasia treated with androgen therapy. 166 cases].
    Presse Med; 1983 May; 12(22):1405-10. PubMed ID: 6222331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.